Ching-Ling (Ellen) Lien, PhD
Education
BS 1993 - National Taiwan University
MS 1995 - National Taiwan University
PhD 2001 - University of Texas, Southwestern Medical Center, Dallas
Postdoctoral Research Fellowship
2006 Children's Hospital of Boston
Harvard Medical School
Accomplishments
Publications
Cavallero S, Shen H, Yi C, Lien CL, Kumar SR, Sucov HM. Dev Cell. 2015 May 26;33(4):469-77. doi: 10.1016/j.devcel.2015.03.018.
Chemokine-guided angiogenesis directs coronary vasculature formation in zebrafish.
Harrison MR, Bussmann J, Huang Y, Zhao L, Osorio A, Burns CG, Burns CE, Sucov HM, Siekmann AF, Lien CL. Dev Cell. 2015 May 26;33(4):442-54. doi: 10.1016/j.devcel.2015.04.001.
Zhao Y, Cao H, Beebe T, Zhang H, Zhang X, Chang H, Scremin O, Lien CL, Tai YC, Hsiai TK. Biomed Microdevices. 2015 Apr;17(2):40. doi: 10.1007/s10544-014-9912-y.
Extracardiac control of embryonic cardiomyocyte proliferation and ventricular wall expansion.
Shen H, Cavallero S, Estrada KD, Sandovici I, Kumar SR, Makita T, Lien CL, Constancia M, Sucov HM. Cardiovasc Res. 2015 Mar 1;105(3):271-8. doi: 10.1093/cvr/cvu269. Epub 2015 Jan 5.
Differential regenerative capacity of neonatal mouse hearts after cryoinjury.
Darehzereshki A, Rubin N, Gamba L, Kim J, Fraser J, Huang Y, Billings J, Mohammadzadeh R, Wood J, Warburton D, Kaartinen V, Lien CL. Dev Biol. 2015 Mar 1;399(1):91-9. doi: 10.1016/j.ydbio.2014.12.018. Epub 2014 Dec 31.
Kang BJ, Park J, Kim J, Kim HH, Lee C, Hwang JY, Lien CL, Shung KK. J R Soc Interface. 2015 Feb 6;12(103). pii: 20141154. doi: 10.1098/rsif.2014.1154.
Research
Heart disease is among the leading causes of death for both adults and children. The goal of the Lien laboratory is to define the molecular and cellular mechanisms of heart regeneration in zebrafish and to enhance regenerative capacity and replacing defective tissues in diseased human hearts. This is especially promising for children since they have better endogenous regenerative capacity than adults. We use genetic, genomic and cellular approaches to dissect the process of heart regeneration and identified promising growth factors, genes and cell types. We will determine how these candidate genes and factors can be utilized to facilitate growth factor and stem cell based therapy. Our work will lead to discovery of important factors and pathways that can contribute to pharmaceutical or cellular therapies for ischemic or congenital heart diseases.
Visit the Lien Laboratory.
